Potential ALS drug gets boost toward preclinical trials
Neuromagen Pharma secures funding to test a new class of small molecules to treat amyotrophic lateral sclerosis and other neurodegenerative diseases.
Stay updated with breaking news from Nucleic Acids. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neuromagen Pharma secures funding to test a new class of small molecules to treat amyotrophic lateral sclerosis and other neurodegenerative diseases.
Biobanks Market: Everything You Need to Know | Micronic Inc., Hamilton Company, Greiner Holding AG, Promega Corporation
Biobanks Market: Everything You Need to Know | Micronic Inc., Hamilton Company, Greiner Holding AG, Promega Corporation
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, publishes its sales performance for the third quarter of 2021 and the year to date. Sales
Challenging the dogma of what scientists thought they understood about DNA viruses, a team of researchers led by Children’s Hospital of Philadelphia